Skip to search formSkip to main contentSkip to account menu

Loss of Chromosome 9q

Known as: del(9q) 
A cytogenetic abnormality that refers to deletion of part of the long arm of chromosome 9. It is associated with the development of acute myeloid… 
National Institutes of Health

Related topics

Related topics

50 relations
Benign Pyriform Fossa NeoplasmBenign Subglottis NeoplasmBenign Supraglottis NeoplasmBenign Thyroid Gland Neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.
To the editor: RUNX1 (also known as AML1 or CBFA2 ) and CBFB encode the α and β subunits of a heterodimeric core binding… 
Highly Cited
2012
Highly Cited
2012
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients 
Highly Cited
2010
Highly Cited
2010
Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
PURPOSE Because cytogenetic data are essential for risk stratification of childhood acute myeloid leukemia (AML), the impact of… 
Highly Cited
2009
Highly Cited
2009
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
Acute myeloid leukemia (AML) with mutated NPM1 usually carries normal karyotype (NK), but it may harbor chromosomal aberrations… 
Review
2008
Review
2008
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
Purpose of review Core-binding factor (CBF) acute myeloid leukemia (AML) is among the most common cytogenetic subtypes of AML… 
Highly Cited
2008
Highly Cited
2008
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
Deletions on chromosome 9q are seen in a subset of acute myeloid leukemia (AML) cases and are specifically associated with t(8;21… 
Highly Cited
2007
Highly Cited
2007
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
We have generated a large, unique database that includes morphologic, clinical, cytogenetic, and follow-up data from 2124… 
Highly Cited
1998
Highly Cited
1998
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
Cytogenetics is considered one of the most valuable prognostic determinants in acute myeloid leukemia (AML). However, many… 
Review
1994
Review
1994
Secondary chromosomal abnormalities in acute leukemias.
Secondary chromosomal aberrations reported in the literature were surveyed in acute myeloid or lymphoblastic leukemia (AML or ALL… 
Highly Cited
1986
Highly Cited
1986
Secondary chromosome aberrations in the acute leukemias.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License